Martin Pruschy Selected Research

Martin Pruschy Research Topics

Disease

47	Neoplasms (Cancer) 04/2022 - 02/2004
10	Hypoxia (Hypoxemia) 06/2021 - 06/2006
8	Carcinoma (Carcinomatosis) 01/2016 - 08/2005
5	Medulloblastoma 05/2018 - 01/2009
4	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2012
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 12/2017
3	Glioma (Gliomas) 01/2018 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 02/2005
3	Adenocarcinoma of Lung 04/2015 - 09/2011
2	Hypersensitivity (Allergy) 04/2022 - 01/2014
2	Residual Neoplasm 01/2020 - 02/2011
2	Squamous Cell Carcinoma of Head and Neck 12/2017 - 07/2007
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Rhabdomyosarcoma 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Malignant Mesothelioma 01/2018
1	Melanoma (Melanoma, Malignant) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Neoplasm Metastasis (Metastasis) 07/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2014
1	Memory Disorders (Memory Loss) 09/2013
1	Fibrosarcoma 04/2013
1	Mesothelioma 12/2012
1	Starvation 12/2012

Drug/Important Bio-Agent (IBA)

10	epothilone B (EPO906)IBA 04/2015 - 02/2005
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 02/2004
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2011 - 02/2004
5	Protons (Proton)IBA 04/2022 - 01/2014
5	Phosphotransferases (Kinase)IBA 05/2018 - 08/2004
5	Excipients (Suspending Agents)IBA 04/2015 - 06/2011
4	Biomarkers (Surrogate Marker)IBA 06/2021 - 06/2011
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2006
4	TubulinIBA 01/2017 - 02/2005
4	vatalanib (PTK787)IBA 06/2011 - 02/2004
3	Radiation-Sensitizing AgentsIBA 06/2021 - 02/2005
3	Biological ProductsIBA 06/2021 - 04/2017
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 10/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 02/2005
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017 - 02/2005
3	taxaneIBA 01/2017 - 02/2005
3	Tyrosine Kinase InhibitorsIBA 06/2011 - 06/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2008 - 06/2006
2	Metalloproteases (Metalloproteinases)IBA 01/2021 - 04/2013
2	Antineoplastic Agents (Antineoplastics)IBA 03/2020 - 01/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2012
2	Cetuximab (Erbitux)FDA Link 01/2020 - 01/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 12/2017
2	Bevacizumab (Avastin)FDA Link 10/2017 - 04/2015
2	Messenger RNA (mRNA)IBA 09/2017 - 02/2011
2	Formaldehyde (Formol)FDA Link 01/2016 - 02/2011
2	ParaffinIBA 01/2016 - 02/2011
2	Conditioned Culture MediaIBA 07/2014 - 04/2013
2	Matrix Metalloproteinases (MMPs)IBA 07/2014 - 04/2013
2	Cytotoxins (Cytolysins)IBA 01/2012 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 08/2004 - 02/2004
2	midostaurinIBA 02/2004 - 02/2004
1	STA 9090IBA 04/2022
1	inositol trispyrophosphateIBA 01/2021
1	FenretinideIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	IntegrinsIBA 05/2018
1	Blocking AntibodiesIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	IonsIBA 01/2018
1	LigandsIBA 01/2018
1	AntigensIBA 01/2018
1	TropomyosinIBA 09/2017
1	ProdrugsIBA 04/2017
1	TH 302IBA 04/2017
1	Oxidoreductases (Dehydrogenase)IBA 04/2017
1	lisavanbulinIBA 01/2017
1	Epothilones (Epothilone)IBA 01/2017
1	BAL27862IBA 01/2017
1	Pemetrexed (MTA)FDA Link 01/2017
1	von Willebrand FactorIBA 01/2016
1	N 30IBA 01/2016
1	Carbonic Anhydrase IXIBA 01/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2015
1	Complement System Proteins (Complement)IBA 04/2015
1	AnaphylatoxinsIBA 04/2015
1	Everolimus FDA Link 04/2015
1	Angiogenesis InhibitorsIBA 04/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2014
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 07/2014
1	Small Interfering RNA (siRNA)IBA 07/2014
1	Hypoxia-Inducible Factor 1IBA 01/2014
1	BAY-84-7296IBA 01/2014
1	Cyclin D2IBA 09/2013
1	Cell ExtractsIBA 04/2013

Therapy/Procedure

17	Therapeutics 01/2020 - 06/2004
16	Radiotherapy 01/2022 - 02/2004
7	Drug Therapy (Chemotherapy) 01/2021 - 08/2005
5	Chemoradiotherapy 01/2020 - 02/2004
2	Aftercare (After-Treatment) 04/2013 - 10/2008
1	Precision Medicine 03/2020
1	Proton Therapy 01/2020
1	Immunotherapy 01/2018
1	Craniospinal Irradiation 09/2017